Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 5.79 is 49% below its 5-year average of 11.24, near the low end of its 5-year range (2.77–20.94).
As of the fiscal period ended Tuesday, June 30, 2026. 45.60% above its 12-month average of 3.98.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.79.
CURRENT RATIO
5.79
CURRENT RATIO AVG TTM
3.98
CURRENT RATIO AVG 3Y
8.78
CURRENT RATIO AVG 5Y
11.24
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+45.60%
CURRENT VS 3Y AVG
-34.08%
CURRENT VS 5Y AVG
-48.51%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+54.37%
vs the sector median at left
Market Cap
$301.07M
Current Ratio
13.28
TTM Avg
4.54
3Y Avg
4.54
5Y Avg
4.54
Market Cap
$301.29M
Current Ratio
34.00
TTM Avg
44.34
3Y Avg
25.02
5Y Avg
19.51
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | $322.03M | 5.79 | 3.98 | 8.78 | 11.24 |
| ClearPoint Neuro, Inc. (CLPT)vs › | $324.34M | 4.73 | 4.57 | 5.38 | 7.09 |
| Sanara MedTech Inc. (SMTI)vs › | $321.44M | 2.58 | 1.99 | 1.74 | 2.06 |
| CapsoVision, Inc. (CV)vs › | $326.76M | 3.35 | 6.00 | 8.25 | 8.25 |
| Avita Medical Inc. (RCEL)vs › | $319.56M | 0.41 | 1.70 | 4.87 | 7.66 |
| Agenus Inc. (AGEN)vs › | $318.77M | 0.34 | 0.31 | 0.55 | 0.87 |
| C4 Therapeutics, Inc. (CCCC)vs › | $312.71M | 5.45 | 6.76 | 6.58 | 6.90 |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $301.07M | 13.28 | 4.54 | 4.54 | 4.54 |
| Benitec Biopharma Inc. (BNTC)vs › | $301.29M | 34.00 | 44.34 | 25.02 | 19.51 |
| Relmada Therapeutics, Inc. (RLMD)vs › | $348.23M | 29.52 | 9.54 | 9.83 | 10.59 |
Current Ratio
5.79
Quick Ratio
5.79
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 5.79 |
| 2026-03-31 | 2.95 |
| 2025-12-31 | 2.77 |
| 2025-09-30 | 3.60 |
| 2025-06-30 | 4.78 |
| 2025-03-31 | 3.96 |
| 2024-12-31 | 6.15 |
| 2024-09-30 | 8.11 |
| 2024-06-30 | 11.52 |
| 2024-03-31 | 12.66 |
| 2023-12-31 | 15.29 |
| 2023-09-30 | 15.65 |
| 2023-06-30 | 20.94 |
| 2023-03-31 | 10.29 |
| 2022-12-31 | 11.47 |
| 2022-09-30 | 15.20 |
| 2022-06-30 | 15.22 |
| 2022-03-31 | 16.07 |
| 2021-12-31 | 14.86 |
| 2021-09-30 | 20.07 |
| 2021-06-30 | 18.75 |
| 2021-03-31 | 26.65 |
| 2020-12-31 | 21.92 |
| 2020-09-30 | 27.95 |
| 2020-06-30 | 37.84 |
| 2020-03-31 | 41.19 |
| 2019-12-31 | 44.66 |
| 2019-09-30 | 23.42 |
| 2019-06-30 | 40.68 |
| 2019-03-31 | 0.00 |
| 2018-12-31 | 36.05 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
